These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7259859)

  • 1. Different behavioral effects following intracerebral, intracerebroventricular or intraperitoneal injections of naloxone in the rat.
    Jacquet YF
    Behav Brain Res; 1980 Dec; 1(6):543-6. PubMed ID: 7259859
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of naloxone on sexual behavior in female rats depends on the site of injection.
    Lindblom C; Forsberg G; Södersten P
    Neurosci Lett; 1986 Sep; 70(1):97-100. PubMed ID: 3774224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S; Ho IK; Yamamoto T
    Brain Res Bull; 2000 Jul; 52(5):363-9. PubMed ID: 10922515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral naloxone and the reaction to thermal noxious stimulation in the rat.
    Woolf CJ
    Brain Res; 1980 May; 190(2):578-83. PubMed ID: 6245770
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat.
    Feng YZ; Zhang T; Rockhold RW; Ho IK
    Neurochem Res; 1995 Jun; 20(6):745-51. PubMed ID: 7566372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects and cerebral pharmacokinetics of apomorphine in the rat: dependence upon the route of administration.
    Melzacka M; Wiszniowska G; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(4):309-17. PubMed ID: 574957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral administration of naloxone and drinking in water-deprived rats.
    Siviy SM; Bermudez-Rattoni F; Rockwood GA; Dargie CM; Reid LD
    Pharmacol Biochem Behav; 1981 Aug; 15(2):257-62. PubMed ID: 7312896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin-induced behavioral, body temperature and electrocortical spectra effects in the rat.
    De Sarro A; Naccari F; De Sarro GB; Ammendola D; Rotiroti D; Trimarchi GR
    Arch Int Pharmacodyn Ther; 1990; 304():125-35. PubMed ID: 2241407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin potently enhances novelty-induced grooming behavior in the rat.
    Drago F; Pedersen CA; Caldwell JD; Prange AJ
    Brain Res; 1986 Mar; 368(2):287-95. PubMed ID: 3697728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular naloxone produces a dose-dependent, monotonic increase in nociceptive threshold in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 May; 515(1-2):323-5. PubMed ID: 2357571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral involvement of endogenous opioid peptides in gastric protection in stressed rats.
    Scoto GM; Parenti C
    Pharmacology; 1996 Jan; 52(1):56-60. PubMed ID: 8966203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression.
    Gogas KR; Presley RW; Levine JD; Basbaum AI
    Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RO 15-1788 produces naloxone-reversible analgesia in the rat.
    Davidovich S; Niv D; Geller E; Urca G
    Eur J Pharmacol; 1988 Jan; 146(1):175-9. PubMed ID: 3127226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ifenprodil on the ACTH-induced behavioral syndrome in rats.
    Genedani S; Bernardi M; Bertolini A
    Eur J Pharmacol; 1994 Jan; 252(1):77-80. PubMed ID: 8149997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of naloxone on ischemic acute kidney injury in the mouse.
    Mutoh J; Ohsawa M; Hisa H
    Neuropharmacology; 2013 Aug; 71():10-8. PubMed ID: 23523991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of acetyl-l-carnitine in the male rat.
    Drago F; Continella G; Pennisi G; Alloro MC; Calvani M; Scapagnini U
    Pharmacol Biochem Behav; 1986 May; 24(5):1393-6. PubMed ID: 3725841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone.
    De Sarro GB; Masuda Y; Ascioti C; Audino MG; Nistico G
    Neuropharmacology; 1990 Feb; 29(2):167-79. PubMed ID: 1691831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.